Bio production considerations when scalingyour therapeutic program tothe clinic and beyond

Scaling up new biotherapeutics from development to commercial production is becoming more and more complex with the growing pipeline of advanced biotherapeutics such as cell and gene therapies, RNA therapeutics, and monoclonal antibody variants.